The development of medical equipment in China has condensed the development of medicine in the past century. Although China is relatively late in the development of medical device innovation, it also lacks accumulation in basic research fields. To achieve the leap from 0 to 1, it takes time, experience, and knowledge to accumulate. Dr. He Qiong, chief scientist of Heskel, a graduate of Tsinghua University, said: "In the process of accumulation, we have always been planted in innovative 'soil', and we are fully committed to promoting technological change and successfully 'breding' a new generation of non-invasive liver disease detection. Technology, and launched a new brand iLivTouch, which has helped the high-quality development of the Chinese medical device industry.
Continuous innovation
As early as 2015, the State Council encouraged domestic medical device companies to strengthen innovation in the "Made in China 2025" plan; in May 2017, the General Office of the Ministry of Science and Technology proposed in the "Thirteenth Five-Year Medical Device Technology Innovation Special Plan" Move towards domesticization, high-end and branding.
At the same time, a series of favorable policies were introduced, which opened up green channels for the innovation of medical equipment and further accelerated the process of "import substitution" for high-end domestic medical equipment. Data show that since 2008, the average annual compound growth rate of the domestic medical device industry in the field of R & D and manufacturing has reached more than 20%. A number of domestic medical device brands have also risen accordingly, and innovative scientific research results have benefited patients, and Heskel is one of the best.
At present, FibroTouch independently developed by Heskel has served millions of people with liver disease, and has occupied an important position in the high-end medical device market. While the road of localization and high-end development is steadily moving forward, this year, Heskel has completely upgraded the brand, launched a new high-end brand iLivTouch, and launched the instantaneous elastography technology (MigTE) based on multi-channel image guidance. ) Max series elasticity detection system. This new product has achieved major breakthroughs in many aspects such as detection accuracy, ease of operation, and clinical functions, and is far ahead of similar products on the market.
“Incubation of innovation achievements is not a“ one-day effort ”. Before the formal launch of the Max series research and development work, we went through rigorous and detailed preliminary investigations and verified the feasibility before starting the project. At the same time, we tried at the beginning of the project Many solutions were evaluated, screened, and tested one by one, and finally an optimal solution was established. The entire research and development process took 5 years to give birth to today's innovations. The Max series has dual-mode cross-boundary fusion probes , To achieve accurate synchronization of ultrasound images and elasticity measurements. "Dr. Qiong He said.
MAX series achieved initial success
Compared with the previous generation of instantaneous elastography, the key of MigTE technology is how to make the signal collect data in multiple channels, and then form an image. Dr. He Qiong explained that each channel represents the number of sources that can be controlled. A probe is composed of multiple seismic sources. Multiple seismic sources can transmit and receive ultrasonic signals at multiple locations, and the obtained data can form an image. In short, multiple signal channels are needed behind the source to collect data. Multi-channel means changing from one location to multiple locations, the signal from one line to multiple lines, and finally a clear image visible to the human eye, bringing convenience to the clinical diagnosis of doctors.
In fact, with the pioneering image integration and intelligent fusion interaction technology, doctors can realize the integration of multi-channel image guidance and elasticity measurement to form multi-directional, comparable images, helping doctors quickly evaluate the liver tissue morphology, and complete liver stiffness and Measurement of fat attenuation parameters. Compared with the liver puncture detection method, the latest Max series has a detection volume of 1000 times the liver puncture specimen. At the same time, the Max series can also observe the position of the liver in real time, achieving WYSIWYG.
At present, the Max series has been put into operation in some hospitals and "first flight" successfully. Dr. He Qiong revealed that the doctors who gave the initial trial gave good feedback to Max. They believe that the image presented by Max is very clear, and the stability and accuracy of detection are very good. In addition, the elastic structure display method can also help correct errors during operation, is easy to operate, and has high detection efficiency.
While bringing convenience to the majority of clinicians, Heskel is also thinking about the direction of future development. Dr. Shao Jinhua, the company ’s general manager, said: "In the future, based on MigTE technology, we hope to make full use of multi-channel energy and develop more functions. For example, for the inflammation of the liver and fatty liver, we plan to combine multi-channel imaging Technology, hoping to collect more liver data and information to provide doctors with more comprehensive help. "